Merck & Company - Comment

Document ID: FDA-2010-D-0462-0008
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: November 12 2010, at 12:00 AM Eastern Standard Time
Date Posted: November 18 2010, at 12:00 AM Eastern Standard Time
Comment Start Date: September 14 2010, at 12:00 AM Eastern Standard Time
Comment Due Date: November 15 2010, at 11:59 PM Eastern Standard Time
Tracking Number: 80b87da3
View Document:  View as format xml

View Comment

Reference 80B8530E This comment letter submission supercede the previous comment letter submitted to the Agency on November 8 (see above reference number)

Attachments:

Merck & Company - Comment

Title:
Merck & Company - Comment

View Attachment: View as format pdf

Related Comments

    View All
Total: 12
Merck & Co, Inc. - Comment
Public Submission    Posted: 11/18/2010     ID: FDA-2010-D-0462-0004

Nov 15,2010 11:59 PM ET
Novartis - Comment
Public Submission    Posted: 11/18/2010     ID: FDA-2010-D-0462-0006

Nov 15,2010 11:59 PM ET
GlaxoSmithKline - Comment
Public Submission    Posted: 11/18/2010     ID: FDA-2010-D-0462-0007

Nov 15,2010 11:59 PM ET
Merck & Company - Comment
Public Submission    Posted: 11/18/2010     ID: FDA-2010-D-0462-0008

Nov 15,2010 11:59 PM ET
Gilead Sciences Inc. - Comment
Public Submission    Posted: 11/18/2010     ID: FDA-2010-D-0462-0010

Nov 15,2010 11:59 PM ET